Quantcast

Latest Endocrinology Stories

2014-06-05 16:27:28

LONDON, June 5, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Post Menopausal Osteoporosis Global Clinical Trials Review, H1, 2014http://www.reportbuyer.com/pharma_healthcare/research_r_d/clinical_trials/post_menopausal_osteoporosis_global_clinical_trials_review_h1_2012.html Post Menopausal Osteoporosis Global Clinical Trials Review, H1, 2014SummaryGlobalData's clinical trial report, "Post Menopausal Osteoporosis Global Clinical Trials Review, H1, 2014"...

2014-06-05 13:15:36

Centre for Addiction and Mental Health Women nearing menopause have higher levels of a brain protein linked to depression than both younger and menopausal women, a new study by the Centre for Addiction and Mental Health (CAMH) shows. This finding may explain the high rates of first-time depression seen among women in this transitional stage of life, known as perimenopause. "This is the first time that a biological change in the brain has been identified in perimenopause which is...

2014-06-04 08:29:58

MISSISSAUGA, ON, June 4, 2014 /CNW/ - Novo Nordisk today announces that the Québec government has approved the inclusion of Victoza(®) (liraglutide), the first once-daily human glucagon-like peptide-1 (GLP-1) analogue, to the Lists of Medications, effective June 2, 2014. The reimbursement of Victoza(®) by the Québec Health Insurance Board (RAMQ) will allow people living with type 2 diabetes to have access to a treatment to help better manage diabetes. Québec is the first...

2014-06-01 23:01:21

Transparency Market Research published a new report "Endocrine Testing Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" to its report store. Browse the full report: http://www.transparencymarketresearch.com/endocrine-testing-market.html. Albany, New York (PRWEB) June 01, 2014 According to a new market report published by Transparency Market Research "Endocrine Testing Market (E2, FSH, hCG, LH, DHEAS, Progesterone, Testosterone, TSH,...

2014-05-29 20:22:54

New offering through an agreement with Meda AB expands Mission's women's healthcare options SAN ANTONIO, May 29, 2014 /PRNewswire/ -- Mission Pharmacal Company has begun exclusive promotion of Elestrin® (estradiol gel) 0.06% in the United States through an agreement with Meda AB. Elestrin is a prescription medicine approved by the Food and Drug Administration (FDA) for use as a topical hormone replacement gel to treat moderate-to-severe hot flashes due to menopause. Using estrogen-alone may...

2014-05-27 12:32:54

PERRIS, Calif., May 27, 2014 /PRNewswire/ -- After several years of research and testing, LC Enterprises has developed a natural powder formula that allows the male body to increase its own testosterone, growth hormone and IGF-1 by several hundred percent. These results are backed by actual blood tests from current users. The formula, called the "Time Machine," causes the body to restore its own hormone production, effectively giving a 50-60+ year old male the hormone levels of a...

2014-05-27 12:31:24

LONDON, May 27, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Blood Glucose Testing and Diabetes Management http://www.reportbuyer.com/pharma_healthcare/diseases/diabetes/blood_glucose_testing_diabetes_management.html There has been a dramatic increase in the incidence of diabetes worldwide, which has been exacerbated by the growing obesity problem across the globe. Once thought of as primarily a childhood disease--sometimes referred to as juvenile...

2014-05-27 12:27:43

Traditional Type 2 Diabetes Drug Attributes Continue to be Key Even as First-Line Treatment Paradigms Shift, According to Findings from Decision Resources Group BURLINGTON, Mass., May 27, 2014 /PRNewswire/ -- Decision Resources Group finds that Eli Lilly's insulin peglispro is set to become the clinical gold-standard in the treatment of patients with type 2 diabetes inadequately controlled with diet and exercise, when metformin is not a therapeutic option. Although metformin continues to...

2014-05-27 12:10:00

Brigham and Women's Hospital Both treatments shown effective for hot flashes and night sweats A new research study from Brigham and Women's Hospital (BWH) that compares low-dose oral estrogen and low-dose non-hormonal venlafaxine hydrochloride extended release (XR) to placebo were both found effective in reducing the number of hot flashes and night sweats reported by menopausal women. The study is the first clinical trial to simultaneously evaluate estrogen therapy (ET), known as the...

2014-05-23 23:05:00

Don’t Pause is currently on special promotion from the AntiAging Institute of California. Beverly Hills, CA (PRWEB) May 23, 2014 Don’t Pause is a popular natural treatment for menopause that can be used during and after menopause. Its herbal ingredients are gentle on a woman’s system and can help restore the balance she needs. For a limited time, the AntiAging Institute of California is now offering a special promotion on Don’t Pause that offers women significant savings....


Latest Endocrinology Reference Libraries

Osteoporosis International
2012-05-17 15:25:40

Osteoporosis International is a peer-reviewed medical journal published monthly by Springer Science+Business Media. It was established in 1990. It is the official journal of the International Osteoporosis Foundation and the National Osteoporosis Foundation. The journal includes original research on all areas of osteoporosis and related fields. It also publishes reviews, educational articles, and case reports. Editors-in-chief are R. Lindsay and J.A. Kanis. According to the Journal...

Diabetes Care
2012-05-12 21:41:27

Diabetes Care is a peer-reviewed medical journal established in 1978 and published monthly by the American Diabetes Association. It covers research in the following five categories: clinical care/education/nutrition/psychosocial research; epidemiology/health services research; emerging treatments and technologies; pathophysiology/complications; and cardiovascular and metabolic risk. The journal also publishes clinically relevant review articles, letters to the editor, and commentaries....

More Articles (2 articles) »
Word of the Day
barghest
  • A goblin in English folklore, often appearing in the shape of a large dog and believed to portend imminent death or misfortune.
  • A ghost, wraith, hobgoblin, elf, or spirit.
The origin of 'barghest' is not known, but it may be from perhaps burh-ghest, town-ghost, or German Berg-geist (mountain spirit) or Bär-geist (bear-spirit).
Related